Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Amazon
AMZN
|
+$597M |
| 2 |
Meta Platforms (Facebook)
META
|
+$497M |
| 3 |
Otis Worldwide
OTIS
|
+$377M |
| 4 |
T-Mobile US
TMUS
|
+$333M |
| 5 |
AbbVie
ABBV
|
+$312M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Apple
AAPL
|
+$457M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$427M |
| 5 |
Accenture
ACN
|
+$245M |
Sector Composition
| 1 | Technology | 23.73% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Copa Holdings
CPA
$4.86B
| $5.41M | ﹤0.01% |
107,015
+4,570
| +4% | +$231K |
|
2302
Spyre Therapeutics
SYRE
$945M
| $5.39M | ﹤0.01% |
23,306
+10,543
| +83% | +$2.44M |
|
2303
Frontline
FRO
$5.17B
| $5.39M | ﹤0.01% |
771,826
+746,385
| +2,934% | +$5.21M |
|
2304
First Mid Bancshares
FMBH
$945M
| $5.38M | ﹤0.01% |
205,059
+5,994
| +3% | +$157K |
|
|
CATC
2305
DELISTED
CAMBRIDGE BANCORP
CATC
| $5.38M | ﹤0.01% |
90,795
+20,664
| +29% | +$1.22M |
|
|
CLDT
2306
Chatham Lodging
CLDT
$348M
| $5.38M | ﹤0.01% |
878,753
+2,062
| +0.2% | +$12.6K |
|
2307
Forrester Research
FORR
$195M
| $5.38M | ﹤0.01% |
167,837
+4,428
| +3% | +$142K |
|
2308
Amerant Bancorp
AMTB
$880M
| $5.38M | ﹤0.01% |
357,513
+33,774
| +10% | +$508K |
|
2309
DHT Holdings
DHT
$1.98B
| $5.36M | ﹤0.01% |
1,045,417
+29,801
| +3% | +$153K |
|
2310
Digi International
DGII
$1.33B
| $5.36M | ﹤0.01% |
460,114
+7,857
| +2% | +$91.5K |
|
|
DSPG
2311
DELISTED
DSP Group Inc
DSPG
| $5.35M | ﹤0.01% |
336,938
+7,155
| +2% | +$114K |
|
2312
Peapack-Gladstone Financial
PGC
$517M
| $5.34M | ﹤0.01% |
285,124
+10,357
| +4% | +$194K |
|
2313
World Acceptance Corp
WRLD
$900M
| $5.34M | ﹤0.01% |
81,487
-2,164
| -3% | -$142K |
|
2314
Green Plains
GPRE
$631M
| $5.32M | ﹤0.01% |
521,166
+11,468
| +2% | +$117K |
|
|
MTEM
2315
DELISTED
Molecular Templates, Inc.
MTEM
| $5.32M | ﹤0.01% |
25,705
+2,275
| +10% | +$471K |
|
2316
Scholar Rock
SRRK
$3.04B
| $5.3M | ﹤0.01% |
290,837
+38,389
| +15% | +$699K |
|
2317
Astrana Health
ASTH
$1.38B
| $5.27M | ﹤0.01% |
319,471
+21,803
| +7% | +$360K |
|
2318
Insteel Industries
IIIN
$749M
| $5.26M | ﹤0.01% |
275,967
+1,886
| +0.7% | +$36K |
|
2319
Replimune Group
REPL
$447M
| $5.25M | ﹤0.01% |
211,463
+29,620
| +16% | +$736K |
|
2320
SI-BONE Inc
SIBN
$677M
| $5.25M | ﹤0.01% |
329,064
+42,975
| +15% | +$685K |
|
2321
Republic Bancorp
RBCAA
$1.48B
| $5.23M | ﹤0.01% |
159,907
-4,279
| -3% | -$140K |
|
|
AD
2322
Array Digital Infrastructure, Inc.
AD
$4.41B
| $5.2M | ﹤0.01% |
168,399
-12,579
| -7% | -$388K |
|
|
PDLI
2323
DELISTED
PDL BioPharma, Inc.
PDLI
| $5.19M | ﹤0.01% |
1,782,834
+68,247
| +4% | +$199K |
|
2324
MannKind Corp
MNKD
$1.71B
| $5.18M | ﹤0.01% |
2,962,327
+276,044
| +10% | +$483K |
|
2325
Independent Bank Corp
IBCP
$657M
| $5.17M | ﹤0.01% |
348,211
+1,988
| +0.6% | +$29.5K |
|